CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for XtalPi Holdings Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

XtalPi Holdings Ltd
3/F, Second Phase of the International
No. 2 Hongliu Road, Futian district
SHENZHEN, GNG  China Ticker: 22282228
Business Summary
XtalPi Holdings Ltd is a holding company primarily engaged in the provision of drug and material science research and development solutions and services in the pharmaceutical and material science industries. The Company mainly operates two businesses. Drug discovery solutions primarily encompass the development of early-stage lead compounds and investigational new drugs, providing research support for clinical trial initiation. Intelligent robotics solutions primarily include solid-state research and development services and automated chemical synthesis services. The Company conducts its business in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board ShuhaoWen 43 11/27/2023 4/28/2017
Chief Executive Officer, Executive Director JianMa 40 11/27/2023 4/28/2017
Chief Financial Officer FeiranZhou 3/10/2026 3/10/2026
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
LCC Therapeutics Ltd. Riverside House, Irwell Street Manchester United Kingdom

Business Names
Business Name
2228
Liverpool ChiroChem Ltd.

General Information
Number of Employees: 1,054 (As of 6/30/2025)
Outstanding Shares: 4,303,371,761 (As of 12/22/2025)
Stock Exchange: HKG


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, March 24, 2026